Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARNA
1051
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.22M | ﹤0.01% |
76,561
+19,166
| +33% | +$1.25M |
|
1052
Fidelity National Financial
FNF
$14.6B
| $5.21M | ﹤0.01% |
124,746
+10,680
| +9% | +$466K |
|
1053
Janus Henderson Short Duration Income ETF
VNLA
$3.33B
| $5.13M | ﹤0.01% |
102,186
+130
| +0.1% | +$6.53K |
|
1054
Starwood Property Trust
STWD
$6.18B
| $5.07M | ﹤0.01% |
+193,744
| New | +$4.94M |
|
1055
Carvana
CVNA
$47.3B
| $5.04M | ﹤0.01% |
83,415
-404,780
| -83% | -$22M |
|
|
SGEN
1056
DELISTED
Seagen Inc. Common Stock
SGEN
| $5.03M | ﹤0.01% |
31,845
-18,901
| -37% | -$2.81M |
|
|
AVDL
1057
DELISTED
Avadel Pharmaceuticals
AVDL
| $5M | ﹤0.01% |
742,772
+489,545
| +193% | +$3.89M |
|
1058
Xerox
XRX
$360M
| $4.91M | ﹤0.01% |
209,125
-7,086
| -3% | -$171K |
|
1059
Arch Capital
ACGL
$37.2B
| $4.9M | ﹤0.01% |
125,905
-26,128
| -17% | -$1.03M |
|
|
VER
1060
DELISTED
VEREIT, Inc.
VER
| $4.89M | ﹤0.01% |
106,461
-1,875,240
| -95% | -$84.9M |
|
1061
Norwegian Cruise Line
NCLH
$9.74B
| $4.85M | ﹤0.01% |
164,855
+57,264
| +53% | +$1.73M |
|
1062
Gartner
IT
$10.4B
| $4.84M | ﹤0.01% |
19,990
-9,155
| -31% | -$2M |
|
1063
Fortis
FTS
$29.7B
| $4.83M | ﹤0.01% |
109,088
-1,900
| -2% | -$85.6K |
|
1064
Avnet
AVT
$7.07B
| $4.82M | ﹤0.01% |
+120,215
| New | +$5.17M |
|
1065
Zai Lab
ZLAB
$2.1B
| $4.8M | ﹤0.01% |
27,136
-6,512
| -19% | -$1.05M |
|
1066
CenterPoint Energy
CNP
$29B
| $4.8M | ﹤0.01% |
195,834
-71,907
| -27% | -$1.76M |
|
1067
Brown-Forman Class B
BF.B
$13.3B
| $4.79M | ﹤0.01% |
63,927
-132,998
| -68% | -$10.1M |
|
1068
MongoDB
MDB
$25B
| $4.78M | ﹤0.01% |
13,219
-83,101
| -86% | -$25.7M |
|
|
PFPT
1069
DELISTED
Proofpoint, Inc.
PFPT
| $4.78M | ﹤0.01% |
+27,488
| New | +$4.46M |
|
1070
NVR
NVR
$17.3B
| $4.77M | ﹤0.01% |
958
-133
| -12% | -$646K |
|
1071
NIO
NIO
$11.7B
| $4.75M | ﹤0.01% |
89,231
-460,399
| -84% | -$18.4M |
|
1072
Ares Management
ARES
$28.8B
| $4.73M | ﹤0.01% |
+74,389
| New | +$4.16M |
|
1073
Howard Hughes
HHH
$4B
| $4.71M | ﹤0.01% |
50,681
+48,391
| +2,113% | +$4.79M |
|
|
HHLA.U
1074
DELISTED
HH&L Acquisition Co. Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant
HHLA.U
| $4.69M | ﹤0.01% |
463,433
+13,433
| +3% | +$136K |
|
1075
Omega Healthcare
OHI
$15.4B
| $4.68M | ﹤0.01% |
128,907
+49,916
| +63% | +$1.85M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.